The Emerging Start-ups session is designed for entrepreneurial scientists preparing to launch start-ups that address unmet needs in animal health and welfare through innovative technologies.
We offer: GMP production of cell/based products at a pilot scale and also scaling for mass production and support of the R&D journey from the lab to submitting a regulatory dossier.
We are interested in collaborations to design, deliver and publish high quality and rigorous research trials on the utility of stem cells for a range of clinical indications.